Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

This study has been completed.
Information provided by:
Teva Pharmaceutical Industries Identifier:
First received: September 13, 2005
Last updated: April 8, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)